Cefalexin shortage — CA supply status & alternatives

Cefalexin

ATC J01DB01

🇦🇺 AUST R 326442

In shortage · Australia

KeflexCeporexCephalexin

In declared shortage · 🇦🇺 Australia & also short in🇨🇦 CA🇺🇸 US

Critical shortage

Product discontinued / no longer available on the Australian market.

Reading today’s signals…

🇦🇺 AUAEMPA$2.50DPMQ A$19.84details →

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Cefalexin
Brand names	Keflex, Ceporex, Cephalexin
ATC level 5	J01DB01
ATC level 4	J01DB
Therapeutic category	Antibacterials — first-generation cephalosporin
Controlled substance	No
Marketing-authorisation holders	Sandoz Pty Ltd, SANDOZ LIMITED, Sandoz GmbH, KENT PHARMACEUTICALS LIMITED +1 more
Registrations on file	22
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$2.50

AEMP

Dispensed (DPMQ)

A$19.84

incl. fees

Pack

cefalexin 500 mg capsule, 20

Source: PBSEffective July 2026 · AUD

Other markets

🇬🇧 GB

£1.61

Drug Tariff

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇦🇺

Australia

TGA · 3h ago

High

🇨🇦

Canada

HC · 13h ago

High

🇬🇧

United Kingdom

MHRA · 1mo ago

Resolved

🇺🇸

United States

FDA MedWatch · 1mo ago

High

Verified timeline regulator events

🇦🇺 26 June 2026

high reported

🇦🇺 1 June 2026

high reported

🇨🇦 12 Mar 2026

high reported

🇨🇦 3 Mar 2026

high reported

🇨🇦 28 Jan 2026

high reported

🇨🇦 8 Jan 2026

high reported

Sources official regulators

🇦🇺

TGA

verified 3h ago

verify ↗

🇨🇦

verified 13h ago

verify ↗

🇬🇧

MHRA

verified 1mo ago

verify ↗

🇺🇸

FDA MedWatch

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders22 registrations · 5 MA holders

Product	Strength	Form	Market	MA holder	Status
Noumed	500 mg	—	🇦🇺 AU	—	Active
Blooms The Chemist	500mg	—	🇦🇺 AU	Sandoz Pty Ltd	Active
CEPHALEXIN-WGR cefalexin	500mg	—	🇦🇺 AU	—	Active
CEPHALEXIN-WGR cefalexin	250mg	—	🇦🇺 AU	—	Active
CEFALEXIN 125MG/5ML ORAL SUSPENSION	125MG	suspension	🇬🇧 GB	SANDOZ LIMITED	Active
CEFALEXIN 250MG/5ML ORAL SUSPENSION	250MG	suspension	🇬🇧 GB	SANDOZ LIMITED	Active
CEFALEXIN 250MG CAPSULES	250MG	capsule	🇬🇧 GB	SANDOZ LIMITED	Active
CEFALEXIN 500MG CAPSULES	500MG	capsule	🇬🇧 GB	SANDOZ LIMITED	Active
CEFALEXIN 500MG TABLETS	500MG	tablet	🇬🇧 GB	Sandoz GmbH	Active
CEFALEXIN 250MG TABLETS	250MG	tablet	🇬🇧 GB	SANDOZ LIMITED	Active
CEFALEXIN 250MG CAPSULE, HARD	250MG	capsule	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active
CEFALEXIN 500MG CAPSULE, HARD	500MG	capsule	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active
CEFALEXIN 250 MG FILM-COATED TABLETS	250 MG	tablet	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active
CEFALEXIN 500 MG FILM-COATED TABLETS	500 MG	tablet	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active
CEFALEXIN 125MG/5ML POWDER FOR ORAL SUSPENSION	125MG	suspension	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active

+7 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.